In the news
2022 Predictions for Health Equity
January 14, 2022
Health equity has long been a challenge, but in 2022 it promises to be a top-of-mind issue. The COVID pandemic has made it clear that health inequity has a broad impact not only on public health, but on the financial well-being of entire communities. It’s time we listen to health equity advocates and turn words into actions in 2022.
Health Equity Defined
The WHO defines health equity as: “the absence of unfair and avoidable or remediable differences in health among population groups defined socially, economically, demographically or geographically.”
Based on this definition, addressing health equity means dealing with many economic, social, and cultural issues. Put simply, it is a multifaceted problem with no silver bullet.
We are in this together
The global COVID-19 pandemic has laid bare how interconnected we are.
We have seen how unequal distribution of vaccines globally can lead to the formation of new virus mutations which spread quickly and negatively impact countries with high vaccination rates. We have also seen how factories that have to be shut down in foreign countries due to COVID has an impact on the price of goods in our local stores…if the item you want is even available.
At a local level, we have seen how unequal access to healthcare impacts absenteeism. The Omicron variant is causing swaths of people to be home sick, including teachers. In some communities, so many teachers are out, elementary and high schools are understaffed which is having an impact on the quality of education students are receiving.
We are finally waking up to what advocates have been saying for years…that health equity is not “their problem”, it’s “our problem”. What happens to one of us in terms of health (or more accurately lack of health), can impact all of us...
...Tom Lemberg, Founder and CEO at Curebase foresees more scrutiny from regulators on diversity in clinical research:
Inequity in access to healthcare continues to plague commercially available care, as well as access to cutting edge clinical research. In the coming year, we will see regulators continue to scrutinize data from studies that do not reflect patient populations in diverse communities. Geography plays a significant role in addressing the challenges associated with access to clinical trials.
At Curebase, our mission is to bring quality medical innovations to patients faster and improve human wellbeing through more efficient clinical studies. We are proving that clinical research can be radically accelerated if we empower physicians everywhere to enroll patients in the communities where they live. By applying cutting edge clinical software and remote study management techniques to the problem, we are reinventing clinical trials and research from the ground up.
SOURCE Healthcare IT Today